Skip to Content

Asparaginase Erwinia chrysanthemi

Last Updated: February 7, 2018
Status: Current

Asparaginase Erwinia chrysanthemi

Products Affected - Description
  • Erwinaze, Jazz Pharmaceuticals
    10,000 unit, 3 mL vial, 5 count (NDC 57902-0249-05)

Reason for the Shortage
  • Jazz Pharmaceuticals has Erwinaze on shortage due to manufacturing issues.

Available Products
  • There is insufficient supply for usual ordering

Estimated Resupply Dates

  • Jazz Pharmaceuticals has Erwinaze available. The company requests that Erwinaze only be ordered for patients who are currently undergoing treatment or initiating treatment.


  • Jazz Pharmaceuticals has sent Dear Health Care Provider letters regarding the administration of certain batches of Erwinaze (Batches 174K, 177K, 178K, 179K, 180K, 181K, 182K, 183K, and 184K). Particulate matter was seen in vials from these batches during routine inspections. Jazz states that the product must be given intramuscularly only and NOT intravenously. Also, 5-micron filter needles are to be used when withdrawing Erwinaze from vials.


February 7, 2018; November 29, September 28 and 13, August 29, June 12, April 25, March 3, January 25, 2017; December 28 and 12, November 18, October 24 and 11, 2016, University of Utah, Drug Information Service. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.